AbbVie's $5.8 billion deal for Stemcentrx was an attempt to diversify its revenue away from Humira, the blockbuster drug
that makes up more than half its sales, with a new, experimental therapy.
After Abbvie (ABBV) announced an agreement to acquire Allergan (AGN) for $120 per share of cash and a remaining $68 in AbbVie shares, Wells Fargo analyst David Maris said he views the deal as a good alternative for Allergan versus the current share price, but he is not convinced its a better long term alternative given the eventual biosimilar threat to Abbvie's blockbuster drug
Get ready for some blockbuster drug
launches that could get intense.
The first generic versions of Pfizer Inc.'s blockbuster drug
for erectile dysfunction were launched this month by Teva Pharmaceutical Industries Ltd.
ALMOST 80,000 adults with psoriasis could be set to miss out on a new blockbuster drug
to treat the disease.
The blockbuster drug
Herceptin is a treatment of choice for many women with HER2-positive breast cancer, but in most cases, resistance to the treatment develops within several years.
In a win for insurance companies and those paying out of pocket for anti-clotting drugs, the patent for the blockbuster drug
, Plavix [R], recently expired.
Following a number of court proceedings between Amgen and the Food and Drug Administration (FDA), the patent of blockbuster drug
Enbrel has been extended to 2028.
According to the report, they predict outcomes and these skills can be leveraged in drug-development, where the chance of striking the right molecule that could be tomorrow's blockbuster drug
is as good as taking a shot in the dark, a drug-company official says, on the ground-breaking initiative.
While Pfizer settled a patent infringement suit with Dr Reddy's over launch of a generic version of the blockbuster drug
in the US, it also signed an agreement with Watson Pharmaceuticals to sell an 'authorized generic' in the US for five years.
The era of the big blockbuster drug
might not be over--but there are signs that many companies are moving away from this all or nothing business strategy.
has sued to force the Food and Drug Administration to speed up the introduction of generic versions of Pfizer's blockbuster drug